Clinical Research Directory
Browse clinical research sites, groups, and studies.
Investigation of the Effect of the Atherogenic Index on the Therapeutic Response to Tadalafil in Patients With Vascular Erectile Dysfunction
Sponsor: Taksim Egitim ve Arastirma Hastanesi
Summary
This study aims to investigate the relationship between the atherogenic index of plasma (AIP) and the therapeutic response to daily tadalafil 5 mg treatment in patients diagnosed with vascular erectile dysfunction (VED). AIP is considered a marker of atherogenic dyslipidemia and subclinical atherosclerosis and is calculated using the formula log10 (triglycerides/HDL-C). Since vascular abnormalities play a major role in the pathophysiology of erectile dysfunction, AIP may reflect underlying vascular risk and potentially predict treatment outcomes. In this prospective observational study, patients with vascular erectile dysfunction will receive tadalafil 5 mg once daily for one month, and treatment response will be evaluated by comparing clinical parameters before and after therapy.
Key Details
Gender
MALE
Age Range
40 Years - Any
Study Type
OBSERVATIONAL
Enrollment
132
Start Date
2025-10-12
Completion Date
2026-04-20
Last Updated
2026-03-18
Healthy Volunteers
No
Locations (1)
Taksim Training and Research Hospital, Istanbul
Istanbul, beyoğlu, Turkey (Türkiye)